Bas van der Woning, PhD

argenx BV
Boston, MA, United States

clinical researcher

Disclosure information not submitted.

Presentation(s):

• L10: Efgartigimod Prevents Necrosis and Allows for Muscle Fiber Regeneration in a Humanized Mouse Model of Immune-mediated Necrotizing Myopathy (IMNM)

  Monday, November 14, 2022
  1:00 PM – 3:00 PM Eastern Time

• L10: Efgartigimod Prevents Necrosis and Allows for Muscle Fiber Regeneration in a Humanized Mouse Model of Immune-mediated Necrotizing Myopathy (IMNM)

  Monday, November 14, 2022
  2:15 PM – 2:20 PM Eastern Time